stockmarket

ASX opens weaker, travel rallies on Tasman bubble, strong open ahead The ASX 200 (ASX:XJO) finished 0.2% lower to open the week, increasing the likelihood of the first negative month since March. The real estate of A-REIT sector was among the few positives, with Scentre Group (ASX:SCG) and GPT Group (ASX:GPT) finished over 2% higher…

Another fintech is heading for the ASX screens, with online mortgage provider Lendi poised to push “go” on an initial public offering (IPO) that could see it list at a market capitalisation of between $500 million-$550 million. Lendi specialises in the home loan market: its software platform matches borrowers with more than 35 lenders. The…

In the middle of 2015, Morgan Stanley Research in Australia published a report which predicted that managed accounts would prove to be a major disruptor of traditional investing via managed funds/unit trusts. The report, ‘Evolution or Revolution?’, seemed overly bullish on the new way for individual investors and their advisers to access professional investment management….

Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…

It’s back: US markets down over 4%, dividends the story of the day, a deal with the devil The ASX 200 (ASX:XJO) finished another 0.8% higher, with everything but the IT, materials and utilities sectors adding to the rally. As reporting season comes to an end, dividend payments are driving daily movements with BHP Group…

Investment markets are in the eye of the storm. The initial storm danger came as COVID-19 hit, decimating jobs and smashing demand.